MASSDEVICE ON CALL — Women’s health company Hologic (NSDQ:HOLX) announced this week former Gen-Probe chairman, president & CEO Carl Hull would step down from his new post at the merged company.
Hull manned the corner office at Gen-Probe up until Hologic acquired the company in a deal worth almost $4 billion, after which he took on a role as the senior vice president and general manager of diagnostics.
Hull will stay with Hologic in a consulting capacity until mid-August 2013, and his SVP and general manager role will be filled by Rohan Hastie, formerly a VP and GM in the women’s health group of the diagnostics division, according to a press release.
Hologic moved up the planned "organizational changes" due to the faster-than-expected integration with Gen-Probe, which the company officially acquired in August 2012.
Former Medicare head eyes a seat in Massachusetts government
Former Medicare chief Donald Berwick may be aiming for a seat in the Massachusetts governor’s office, with a new fundraising effort representing the latest indication of a possible run for office.
Read more
Next-gen exoskeleton opens up rehab to a wider range
Argo Medical touted version 2.0 of its ReWalk Rehabilitation system, an exoskeleton designed to support a larger range of body types to help patients with spinal injuries.
Read more
Cloud-based diagnostics brings HIV testing to remote places
Columbia University researchers developed a "lab-on-a-chip" method of checking a patient’s HIV status and update the results with a central database, doing so 10 times faster that bench-top tests.
Read more